Jason Stutman is Angel Financial's senior technology analyst and editor of investment advisory newsletters Technology and Opportunity and The Cutting Edge. His strategy for building winning portfolios is simple: Buy the disruptor, sell the disrupted. In today's rapidly changing market landscape, Jason helps keep his readers informed on the market's most important and evolving technological trends.
Briton makes use of fundamental analysis, technical analysis, and good old-fashioned horse sense to help individual investors grow their wealth. He's a firm believer that hard work and thorough research leads to investment success.
Jeff Siegel is the managing editor of Energy and Capital, Wealth Daily, Green Chip Stocks, and Liberty Briefing, and contributing analyst for the Energy Investor, an independent investment research service that focuses primarily on stocks in the oil & gas, modern energy and infrastructure markets.
He's known as the original "Bull on America." Since 1994, Brian has shown investors how to profit from America's innovative and information-based economy.
With more than 30 years of recommending stocks under his belt, Charles has knocked the cover off the ball by compiling an amazing record of success and by posting gain after gain for his loyal readers.
Utilizing a unique blend of value investing coupled with a specific catalyst he calls "The Hammer, Trigger and Spark System," Christian keeps your money in play and ensures rapid profits.
A true insider in the energy markets, Keith's research has helped thousands of investors capitalize off the rapidly changing face of energy. Keith is one of the only financial reporters around who's actually visited Alberta's remote tar sands region to personally meet every major player in the booming Canadian oil operation.
Alex Koyfman is the managing editor and investment director of the Penny Stock Millionaire investment advisory, and a contributing editor to Wealth Daily. An avid trader since his late teens, Alex's expertise lies in high-upside, development stage technology and biotech companies.